SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
Open accessPublished version of a preprint
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Background: Cancer cells are characterized by uncontrolled cell proliferation and impaired bioenergetics. Sirtuins are a family of highly conserved enzymes that play a fundamental role in energy metabolism regulation. SIRT1, in particular, drives many physiological stress responses and metabolic pathways following nutrient deprivation. We previously showed that SIRT1 activation using SCIC2.1 was able to attenuate genotoxic response and senescence. Here, we report that in hepatocellular carcinoma (HCC) cells under glucose-deprived conditions, SCIC2.1 treatment induced overexpression of SIRT1, SIRT3, and SIRT6, modulating metabolic response. Methods: Flow cytometry was used to analyze the cell cycle. The MTT assay and xCELLigence system were used to measure cell viability and proliferation. In vitro enzymatic assays were carried out as directed by the manufacturer, and the absorbance was measured with an automated Infinite M1000 reader. Western blotting and immunoprecipitation were used to evaluate the expression of various proteins described in this study. The relative expression of genes was studied using real-time PCR. We employed a Seahorse XF24 Analyzer to determine the metabolic state of the cells. Oil Red O staining was used to measure lipid accumulation. Results: SCIC2.1 significantly promoted mitochondrial biogenesis via the AMPK-p53-PGC1α pathway and enhanced mitochondrial ATP production under glucose deprivation. SIRT1 inhibition by Ex-527 further supported our hypothesis that metabolic effects are dependent on SIRT1 activation. Interestingly, SCIC2.1 reprogrammed glucose metabolism and fatty acid oxidation for bioenergetic circuits by repressing de novo lipogenesis. In addition, SCIC2.1-mediated SIRT1 activation strongly modulated antioxidant response through SIRT3 activation, and p53-dependent stress response via indirect recruitment of SIRT6. Conclusion: Our results show that SCIC2.1 is able to promote energy homeostasis, attenuating metabolic stress under glucose deprivation via activation of SIRT1. These findings shed light on the metabolic action of SIRT1 in the pathogenesis of HCC and may help determine future therapies for this and, possibly, other metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 may improve the liver’s antioxidant capacity and metabolic function by activating Sirt1, thereby helping to alleviate the pathological changes associated with NASH.”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [517]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 1×
“Several studies report that activation of SIRT1 results in energy homeostasis via mitochondrial biogenesis [29–32].”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., & Chen, D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.015 · Cited by 1,310 · cited 1×
“4c) involved in the ROS production [53].”
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210 · cited 1×
“SIRT1 and SIRT3 are known to regulate ROS production and promote cell longevity and metabolic adaptations [35, 36].”
BackgroundFasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan
Longo, V. D., & Panda, S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.001 · Cited by 1,013 · cited 1×
“During fasting or prolonged glucose deprivation, hepatocytes play a key role in energy metabolism [27], and SIRT1 is involved in regulating hepatic metabolism [28].”
BackgroundEnergy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
ZHENG, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 963 · cited 1×
“For instance, under nutrient deprivation, cancer cells switch from glycolytic metabolism to OXPHOS in order to meet energy demands [51].”
BackgroundLuen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740 · cited 1×
“Specifically, under glucose-deprived conditions in cancer cells, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1α) promotes oxidative metabolism to maintain energy homeostasis [18, 19].”
BackgroundViollet, B., Foretz, M., Guigas, B., Horman, S., Dentin, R., Bertrand, L., Hue, L., & Andreelli, F. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108506 · Cited by 528 · cited 1×
“Glucose deprivation in hepatocytes is reported to activate AMPK, modulating the expression of PGC1α similarly to SIRT1 [47].”
BackgroundSirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 487 · cited 1×
“SIRT1 is a well-studied member of the sirtuin family and is known as a stress-responsive protein deacetylase [4].”
BackgroundEmerging roles of SIRT1 in fatty liver diseases
Ding, R.-B., Bao, J., & Deng, C.-X. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19370 · Cited by 359 · cited 1×
“During fasting or prolonged glucose deprivation, hepatocytes play a key role in energy metabolism [27], and SIRT1 is involved in regulating hepatic metabolism [28].”
Background
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Shen, H., Qi, X., Hu, Y., Wang, Y., Zhang, J., Liu, Z., & Qin, Z. (2024) · Theranostics · doi:10.7150/thno.100667 · Cited by 110
“1 was able to govern mitochondrial activity in a time-dependent manner by reducing SOD2 expression and regulating SIRT3 expression [218].”
BackgroundAn, H., Jang, Y., Choi, J.-I., Hur, J., Kim, S., & Kwon, Y. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.188 · Cited by 80
SIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets
Yang, L., Liu, D., Jiang, S., Li, H., Chen, L., Wu, Y., Essien, A. E., Opoku, M., Naranmandakh, S., Liu, S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116917 · Cited by 67
Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
Li, J., Liu, Y., Zheng, R., Qu, C., & Li, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122540 · Cited by 37
Metadata
- Authors
- Varghese, B., Chianese, U., Capasso, L., Sian, V., Bontempo, P., Conte, M., Benedetti, R., Altucci, L., Carafa, V., & Nebbioso, A.
- Affiliations
- University of Campania "Luigi Vanvitelli" (IT)
- Corresponding author
- Altucci, Lucia
- Nebbioso, Angela
- ORCID
- Venue
- Journal of Translational Medicine
- Published
- 2023-09-15
- Volume
- 21
- Issue
- 1
- Pages
- 627-627
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC10504761
- OpenAlex
- W4386763081
- Cited by
- 31
- References
- 59
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 2
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- PRIN2020 (CW39SJ)
- ANTHEM (CUPB53C22006540001)
- PNRR (M6/C2)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- SIRT1, hepatocellular carcinoma, glucose deprivation, energy homeostasis, mitochondrial biogenesis, SIRT3, SIRT6, fatty acid oxidation, de novo lipogenesis, antioxidant response, cancer metabolism, EX527, lipid accumulation
- MeSH terms
- Carcinoma, Hepatocellular, Homeostasis, Humans, Liver Neoplasms, Tumor Suppressor Protein p53, Sirtuins, Sirtuin 1, Sirtuin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism. https://app.cochat.ai/papers/10.1186/s12967-023-04440-9
- The paper
- Varghese, B., Chianese, U., Capasso, L., Sian, V., Bontempo, P., Conte, M., Benedetti, R., Altucci, L., Carafa, V., & Nebbioso, A. (2023). SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04440-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.